The 2017 nosology defines the new criteria for hypermobile Ehlers-Danlos syndrome (hEDS), which is now considered one end of a continuous spectrum encompassing isolated, nonsyndromic joint hypermobility (JH) and hypermobility spectrum disorders (HSDs). Preliminary data indicate a link between JH and neurodevelopmental disorders and, in particular, developmental coordination disorder (DCD) in children. Assessing DCD in adults is difficult and the recently described functional difficulties questionnaire 9 (FDQ-9) is one of the few available tools. The aims of this study are to (a) validate FDQ-9 written in Italian and present normal values in 230 Italian controls; (b) explore the relationship of FDQ-9 with the brief pain inventory, composite autonomic symptom score 31, multidimensional fatigue inventory, attention deficit/hyperactivity disorder self-report version 1.1, and the SF-36 for quality of life in 105 Italian adults with hEDS/HSD. Validation of the FDQ-9 in Italian was carried out by translation, cross-cultural adaptation and test/ retest reliability analysis. A case-control study was performed comparing the FDQ-9 outcome between 105 patients and 105 sex-and age-matched controls. Fifty-nine percent of the patients resulted positive compared to the 3.8% of controls (p value < .00001). In patients, FDQ-9 positive result associated with positive attention deficit/hyperactivity disorder self-report version 1.1 (OR = 4.04). Multivariate regression analysis comparing FDQ-9 with the other questionnaires demonstrated a strong association between positive FDQ-9 and the number of painful joints.
spectrum disorders (HSDs; . HSDs are terms used to defined symptomatic individuals with JH who do not meet the new diagnostic criteria of hEDS .
One of the aims of the 2017 international classification was to solve the nosologic conundrum of the hEDS and the "old" joint hypermobility syndrome (JHS). Previous literature identified hEDS with the Villefranche criteria (Beighton, De Paepe, Steinmann, Tsipouras, & Wenstrup, 1998) and the JHS by the Brighton criteria (Grahame, Bird, & Child, 2000) , a fact suggesting that the two disorders are distinct. One decade afterwards, a community of experts declared that the two disorders are indistinguishable on clinical grounds and, therefore, that they should be considered a single disorder (Tinkle et al., 2009) . Now, hEDS is recognized by novel criteria, and the JHS is removed and incorporated within the HSDs, which do not overlap hEDS.
In hEDS/HSD, quality of life (QoL) is frequently affected because of chronic pain and fatigue (Castori et al., 2012 Pacey, Tofts, Adams, Munns, & Nicholson, 2015) , and partly influenced by autonomic dysfunction (De Wandele et al., 2016) . Co-morbidities are strong QoL determinants in hEDS/HSD, but the nature of their link with JH remains obscure. Fragmented data indicate that the association between JH and neurodevelopmental disorders is a potential field of interest. Daily practice on children with hEDS/HSD suggests a high rate of developmental motor and coordination disorders (Ghibellini, Brancati, & Castori, 2015) . In 2005, Adib, Davies, Grahame, Woo, & Murray (2005) reported clumsiness and symptoms of poor coordination in 125 children with hEDS/HSD. In two studies, Kirby et al. suggested functional similarities between children with GJH or hEDS/HSD and those with developmental coordination disorder (DCD; Kirby & Davies, 2007; Kirby, Davies, & Bryant, 2005) . Accordingly, GJH is more frequent in children with DCD (Celletti et al., 2015; Jelsma, Geuze, Klerks, Niemeijer, & Smits-Engelsman, 2013) as well as in those with the commonly co-morbid attention deficit and hyperactivity disorder (ADHD), compared to controls (Koldas Dogan, Taner, & Evcik, 2011; Sinibaldi, Ursini, & Castori, 2015) . Nevertheless, DCD and ADHD are well-defined diagnoses only in the developmental age.
The functional difficulties questionnaire 9 (FDQ-9) and ADHD self-report version 1.1 (ASRS-V1.1) are among the few tools able to explore DCD-and ADHD-related symptoms in adults (Clark, Thomas, Khattab, & Carr, 2013; Kessler et al., 2005) . The FDQ-9 was first presented in 2013 as a reliable tool for screening adults for a possible diagnosis of DCD. In the original paper, the general psychometric properties of FDQ-9 were investigated in 167 subjects from the general population and 90 patients who attended a hypermobility clinic (Clark et al., 2013) . In a comparable sample of 90 JHS adults, the same group demonstrated a 56% prevalence of positive FDQ-9 screening, with a 5.5 odds ratio (OR) compared to 113 healthy volunteers (Clark, Khattab, & Carr, 2014) . In a further work, the significance of FDQ-9 in relationship with the SMART wobbleboard was explored in healthy adults (Clark, Clark, Dorey, & Williams, 2016) . Nevertheless, studies exploring the relevance of this test in a clinical setting are still lacking.
This work was aimed to (a) validate FDQ-9 in Italian and present its pattern in 230 Italian controls, and (b) explore, for the first time, the relationships of FDQ-9 with the brief pain inventory (BPI) for pain, composite autonomic symptom score 31 (COMPASS-31) for autonomic symptoms, multidimensional fatigue inventory 20 for fatigue, ASRS-V1.1 for ADHD features, and the Short (Castori et al., 2014; Castori & Colombi, 2015) . As data for this study were obtained before the publication of the 2017 International Classification, patients were originally selected according to the Villefranche and Brighton criteria (Beighton et al., 1998; Grahame et al., 2000) . Retrospectively, clinical data of selected patients were compared to the hEDS criteria of the 2017 International Classification and the alternative diagnoses of hEDS and HSD were annotated. In case of a suspected overlap with other acquired or hereditary connective tissue disorders, differential diagnosis extended to autoimmune rheumatologic screening, heart ultrasound, bone densitometry and other selected supplementary ascertainments (i.e., ophthalmologic survey, brain and spine MRI). When necessary, other sets of criteria, such as the revised Ghent criteria for Marfan syndrome (Loeys et al., 2010) , were applied together with the use of appropriate molecular studies. No patients had evidence of intellectual disability or autism spectrum disorder.
Italian controls were enrolled from colleagues and friends of the authors, as well as from the healthy individuals and their relatives attending prenatal screening at the San Camillo-Forlanini Hospital.
Among these controls, three were bilingual native Italian speakers (see below). All clinical and controls gave their consent to the study, which is in accordance to the revised version of the Helsinki Declaration. This study was approved by the Local Ethics Committee (protocol no. 250/CE Lazio 1).
| Translation and cross-cultural adaptation of FDQ-9
The FDQ-9 is a 9-items self-assessment instrument to indicate functional difficulties associated with DCD/dyspraxia, previously validated in English patients by Clark and colleagues (Clark et al., 2013) . For each question, "very good" answers were calculated as 1 point, "good" as 2 points, "poor" as 3 points, and "very poor" as 4 points. According to the original description of FDQ-9 (Clark et al., 2013) , the cut-off above which functional difficulties impacting daily functional activities was fixed at 21.5, whereas a result ranging from 19 to 21 was considered borderline for difficulties impacting daily function. A score of 18 or below was considered negative for functional difficulties.
Three bilingual native Italian speakers independently translated the FDQ-9 questionnaire into Italian (forward translation phase). Subsequently, a consensus was reached on a first preliminary Italian version based on the three translations. Next, two bilingual native English speakers retranslated the Italian version into English (back translation phase). Any inconsistency was resolved. Reproducibility, or test/retest reliability, was assessed using the questionnaires of 45 individuals (20 hEDS/HSD and 25 controls) who completed the questionnaire and a second copy in a period of 8 weeks after the first administration.
| Reference values of FDQ-9 in Italian controls
Once translated and cross-culturally adapted, the Italian version of the 
| ASRS-V1.1
The attentive-executive domain was evaluated in the patients' sample by the ASRS-V1.1, which was originally developed for adults screening by the WHO together with revision of the WHO Composite International Diagnostic Interview (Kessler et al., 2005 (Kessler et al., , 2007 . The ASRS-V1.1 is a symptom checklist for the DSM-IV-TR criteria of ADHD (APA, 2000) . The six questions of the part A of ASRS-V1.1 were found to be the most predictive for ADHD and were considered the basis for the ADHD screening in adults. ASRS-V1.1 was given to patients in its Italian version (freely downloadable at: https://www. aifa.it/documenti/ASRSV1.1.pdf).The sum of the six answers corresponds to how the adult patient has felt and acted in the last 6 months. The cut-off for suspecting ADHD in adults is currently four or more positive answers, calculated on the basis of frequency for each item. The results emerging from this evaluation may suggest the need for a more in-depth clinical analysis in order to confirm or discard the diagnosis, which remains difficult in adults. However, ASRS-V1.1 was calibrated to DSM-IV-TR criteria, which are narrower than the recently developed DSM-5 criteria (APA, 2013) . The present work started before the publication of the DSM-5 updated version of this questionnaire, in which, however, the six questions of part A remain unchanged (Ustun et al., 2017) . ASRS-V1.1 was never used in hEDS/HSD.
| BPI
The Italian version of BPI was used to explore pain features in hEDS/ HDS adults (Caraceni et al., 1996) . BPI is a self-administered multidimensional questionnaire for the evaluation of pain and analyzes four domains including history, location, intensity and interference with daily functions (Cleeland & Ryan, 1994) . BPI can be used in adults and, consists of 13 items exploring time course of pain, pain extension, pain intensity, pain therapies, pain interference with motor and relational activities, and with sleeping and mood. For the present study, replies to questions no. 3-6, 8, and 9 were used as continuous variables. Concerning question no. 2 (homunculus for painful sites pointed by the patient with a pen), each painful point counted 1 and the sum was used as a continuous variable ("bodily pain"). In case of painful points clearly corresponding to joints a second continuous variable was extracted, specific for "joint pain". No previous study on EDS has applied this test.
| MFI-20
MFI-20 was used for assessing fatigue in hEDS/HSD patients by using its Italian version (Jereczek-Fossa et al., 2007) . MFI-20 is a 20-item self-report scale that measures fatigue symptoms in adults. Items are grouped into five areas (general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity) each composed of four items (Smets, Garssen, Bonke, & De Haes, 1995) . All items require an evaluation on a five-point scale, ranging from an answer in accordance with the question "yes, it's true" (= 1 point) to an answer of total disagreement "no, it's not true" (= 5 points). For scoring, it is first necessary that items 2, 5, 9, 10, 13, 14, 16, 17, 18, and 19 are overturned (1 point à 5 points, 2 points à 4 points, 3 points à 3 points, 4 points à 2 points, 5 points à 1 point). Items compose the five areas as follows: items 1, 5, 12, and 16 refer to "general fatigue" (MFI20-GF); items 2, 8, 14, and 20 refer to "physical fatigue"(M-FI20-PF); items 3, 6, 10, and 17 refer to "reduction of activities"(M-FI20-RA); items 4, 9, 15, and 18 refer to "reduction of motivation"(MFI20-RM); and items 7, 11, 13, and 19 refer to "mental fatigue"(MFI20-MF). Accordingly, all areas have a total subscale score ranging from 4 to 20. A higher score in each item and subscale is equivalent to a greater presence of related symptoms. The "general fatigue" subscale is considered the best indicator to assess fatigue with a single score (Smets et al., 1995) . MFI-20 was previously used in hEDS by our group in a single study (Celletti, Castori, La Torre, & Camerota, 2013) .
| COMPASS-31
COMPASS-31 is a self-assessment instrument to evaluate dysautonomic symptoms based on 31 items grouped in six autonomic domains, including four items for orthostatic intolerance (COMPASS31-OI), three items for vasomotor (COMPASS31-VM), four items for secretomotor (COMPASS31-SM), 12 items for gastrointestinal (COMPASS31-GI), three items for bladder (COMPASS31-B), and five items for pupillomotor (COMPASS31-PM) functions (Sletten, Suarez, Low, Mandrekar, & Singer, 2012 ). An Italian version of COMPASS-31 was previously validated and translated (Pierangeli et al., 2015) . For scoring simple questions (e.g., presence vs. absence), negative and positive answers were calculated as 0 and 1 points, respectively. Frequency of symptoms was scored as 0 point for rarely or never reported, 1 point for occasionally or sometimes reported, 2 points for frequently reported or reported "a lot of the time", and 3 points for almost always or constantly reported. Severity of symptoms was calculated as 1 point for mild degree, 2 points for moderate degree, and 3 points for severe degree. For the time course of a symptom, 0 points were attributed for responses such as "gotten somewhat better", "gotten much better", "completely gone", and "I have not had any of these symptoms"; 1 point for "stayed about the same"; 2 points for "gotten somewhat worse"; and 3 points for "gotten much worse".
Every domain is considered as single score derived by the sum of related items. No previous study on EDS applied COMPASS-31.
| SF-36
Health status and particularly QoL were assessed by administering the SF-36 questionnaire to the patients' sample. SF-36 has an Italian version (Apolone & Mosconi, 1998) , which was previously used in EDS adults by our group and others (Castori, Camerota, Celletti, Grammatico, & Padua, 2010; Celletti et al., 2013; Rombaut, Malfait, Cools, De Paepe, & Calders, 2010) . SF-36 is a useful self-report 36-item questionnaire consisting of eight subscales that describe physical activity (PA), physical role limitations (PRL), physical pain (PP), general health (GH), vitality (V), social activity (SA), emotional role limitations (ERL), and mental health (MH) over the past 4 weeks. Every scale ranges from 0 to 100, with 0 indicating the negative lowest score and 100 indicating the positive highest score. These eight scales are then grouped in three areas, named physical health (PH = PA + PRL + PP), general health (GH + V) and psychological-emotional health (PEH = SA + ERL + MH). These scales were calculated using the algorithm freely available online and fully applicable to the Italian version of SF-36 (freely downloadable at: http://crc.marionegri.it/sf36/ sf36v1ita.htm). 
| Statistical methods

| Validation of FDQ-9 in Italian
The translation in Italian of the FDQ-9 questionnaire is reported in Table 1 
| Relationships of the FDQ-9 with the other questionnaires in hEDS/HSD adults
In the 105 adults with hEDS/HSD, the results of the FDQ-9 were com- 
| DISCUSSION
This work includes the validation of the FDQ-9 questionnaire in a second language and, for the first time, explores its impact on selected with JH as well as the newly defined hEDS), and (c) HSDs . At the same time, the existence of a continuous spectrum is accepted ranging from isolated, nonsyndromic JH, to the various HSDs, to hEDS. This spectrum is the background family of phenotypes, in which patients with various forms of JH (symptomatic and asymptomatic, isolated and combined with other features), who are not associated with a specific genetic defect, are grouped. Isolated, nonsyndromic JH, and HSD are, in turn, subclassified according to the type of JH. In fact, patterns of JH include generalized JH, localized JH, peripheral JH, and historical JH on the basis of the Beighton score, five-point questionnaire and presence/absence of JH in joints outside the Beighton score . This study focused on "symptomatic" patients belonging to the above described spectrum (i.e., patients affected by HSDs and hEDS).
Within such a heterogeneous group of patients, who, in the past, Intensity, minimum 3.0 0-10 4.0 0-9 .106
Intensity, mean 4.0 0-10 6.0 2-10 .002
Intensity, current 4.0 0-10 6.0 0-9 .013
Interference, GA 5.0 0-10 7.0 0-10 .012
Interference We recently contributed to this issue by comparing 23 children affected by hEDS/HSD, classical EDS and Loeys-Dietz syndrome with a control group of children primarily ascertained for DCD (Piedimonte et al., 2018) . In the "syndrome" group we found DCD, ADHD, and learning disabilities in 30%, 13%, and 22% of the cases, respectively.
Conversely, in the DCD group, none had full characteristics of hEDS/ HSD or other Mendelian disorders with JH; a fact which suggests a low rate of "syndromic diagnoses" in children primarily ascertained for DCD. The pattern of neuropsychiatric and neurodevelopmental attributes of children with syndromic DCD (first group) and whose with nonsyndromic DCD (second group) significantly differed for the severity and range of somatic complaints and behavioral traits (Piedimonte et al., 2018) .
In the present work, we formalized the known association between hEDS/HSD, DCD, and ADHD in adults. Although the diagnosis of DCD and ADHD are difficult in the postdevelopmental age, the two applied screening tools, that is, FDQ-9 and ASRS-V1.1, are considered reliable for a clinical suspicion of these conditions in adults.
Accordingly, 59% and 52% of the sample resulted positive to FDQ-9
and ASRS-V1.1, respectively. This rate is likely to be an overestimation as the data relates to self-reported complaints. This is partly supported by the lower rate of proved diagnoses of DCD and ADHD in our previous "pediatric" study (Piedimonte et al., 2018) . Nevertheless, our data demonstrate a high rate of complaints related to impaired coordination and attention in adults with hEDS/HSD. Interestingly, the rate of 59% of "positive" FDQ-9 (i.e., >21) in the patients' sample is comparable to the 56% in a previous work on 90 women with JHS by Clark et al. (2014) . Our findings also mirrored what happens in the general pediatric population in which ADHD and DCD are common co-morbidities. This is reflected by the results of the FDQ-9 and ASRS-V1.1, which are significantly associated in our clinical sample.
The strong association between positive ASRS-V1.1 for ADHD and hEDS/HSD in our study confirms what has previously been explored by a Swedish retrospective nationwide study which showed that EDS seems to predispose to ADHD with a 5.6 relative risk (Cederlöf et al., 2016) . These findings may be interpreted in line with the well-known impairment of proprioception and fear of falling in adults with JH or hEDS (Rombaut et al., 2011; Scheper et al., 2017) .
Multivariate logistic regression analysis showed a strong association between positive FDQ-9 and the number of painful joints in adults with hEDS/HSD. Interpretation of this finding is not clear-cut.
However, some hypothesis can be put forward. First, a "clumsy" individual is more prone to soft-tissue injuries, falls and joint traumas; a mechanism that might explain a high rate of post-traumatic joint pain in adults with JH and features of DCD. Available data also suggest a link between clumsiness and impaired proprioception in individuals with JH. Therefore, it is possible that subjects who are born with JH also present an impaired proprioception during their developmental age. It is presumed by the recent identification of significant impairment of postural controls in children with EDS (Lisi et al., 2017) . This might facilitate the instauration of atypical motor schemes which predispose a lax joint to microtraumas and, hence, to the development of recurrent and chronic joint pain in children and adults. Therefore, our findings reinforce the link between the severity of functional difficulties and the rate of chronic widespread pain in hEDS/HSD, as previously hypothesized in JHS adults by Clark et al. (2014) . In this perspective, in the hypermobile child, the presence of DCD might be tigations. Accordingly, this is an exploratory study aimed at raising attention of the neuropsychological attributes of JH, which may exist also beyond the developmental age and contribute to disability in adults.
In conclusion, our work validates the FDQ-9 test as a reliable screening tool for DCD in Italian adults. The patterns of replies to the nine items of the FDQ-9 in 230 Italian controls can be used as normative values for future studies which will apply FDQ-9 in different Italian patients' cohorts. We also demonstrated a high rate of a "likely" 
